ASCO & EHA 2025: Novartis unveils new data on key therapies and expands focus on early detection and patient-centered initiatives
2025 American Society of Clinical Oncology (ASCO) Annual Meeting and the European Hematology Association (EHA) 2025 Congress. “The breadth of our oncology and hematology portfolio – anchored by… read more.